Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)

Delayed Data
As of Sep 21
 -0.025 / -1.85%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.40 and a low estimate of 1.11. The median estimate represents a -5.28% decrease from the last price of 1.33.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Zynerba Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.76%
Growthannually 6.91%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.